100 related articles for article (PubMed ID: 15231848)
1. Disorder in a target for the smad2 mad homology 2 domain and its implications for binding and specificity.
Chong PA; Ozdamar B; Wrana JL; Forman-Kay JD
J Biol Chem; 2004 Sep; 279(39):40707-14. PubMed ID: 15231848
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of Smad2 recognition by the Smad anchor for receptor activation.
Wu G; Chen YG; Ozdamar B; Gyuricza CA; Chong PA; Wrana JL; Massagué J; Shi Y
Science; 2000 Jan; 287(5450):92-7. PubMed ID: 10615055
[TBL] [Abstract][Full Text] [Related]
3. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.
Tsukazaki T; Chiang TA; Davison AF; Attisano L; Wrana JL
Cell; 1998 Dec; 95(6):779-91. PubMed ID: 9865696
[TBL] [Abstract][Full Text] [Related]
4. Different Smad2 partners bind a common hydrophobic pocket in Smad2 via a defined proline-rich motif.
Randall RA; Germain S; Inman GJ; Bates PA; Hill CS
EMBO J; 2002 Jan; 21(1-2):145-56. PubMed ID: 11782434
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
6. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
[TBL] [Abstract][Full Text] [Related]
7. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling.
Imoto S; Sugiyama K; Sekine Y; Matsuda T
FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling.
Wu JW; Hu M; Chai J; Seoane J; Huse M; Li C; Rigotti DJ; Kyin S; Muir TW; Fairman R; Massagué J; Shi Y
Mol Cell; 2001 Dec; 8(6):1277-89. PubMed ID: 11779503
[TBL] [Abstract][Full Text] [Related]
9. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
10. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
[TBL] [Abstract][Full Text] [Related]
11. The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-beta/Smad signalling.
Itoh F; Divecha N; Brocks L; Oomen L; Janssen H; Calafat J; Itoh S; Dijke Pt Pt
Genes Cells; 2002 Mar; 7(3):321-31. PubMed ID: 11918675
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of a transcriptionally active Smad4 fragment.
Qin B; Lam SS; Lin K
Structure; 1999 Dec; 7(12):1493-503. PubMed ID: 10647180
[TBL] [Abstract][Full Text] [Related]
13. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation.
Harada J; Kokura K; Kanei-Ishii C; Nomura T; Khan MM; Kim Y; Ishii S
J Biol Chem; 2003 Oct; 278(40):38998-9005. PubMed ID: 12874272
[TBL] [Abstract][Full Text] [Related]
14. The Smad pathway.
Wrana JL; Attisano L
Cytokine Growth Factor Rev; 2000; 11(1-2):5-13. PubMed ID: 10708948
[TBL] [Abstract][Full Text] [Related]
15. Structure of the N-terminal domain of the protein Expansion: an 'Expansion' to the Smad MH2 fold.
Beich-Frandsen M; Aragón E; Llimargas M; Benach J; Riera A; Pous J; Macias MJ
Acta Crystallogr D Biol Crystallogr; 2015 Apr; 71(Pt 4):844-53. PubMed ID: 25849395
[TBL] [Abstract][Full Text] [Related]
16. The nuclear import function of Smad2 is masked by SARA and unmasked by TGFbeta-dependent phosphorylation.
Xu L; Chen YG; Massagué J
Nat Cell Biol; 2000 Aug; 2(8):559-62. PubMed ID: 10934479
[No Abstract] [Full Text] [Related]
17. Repression of Smad2 and Smad3 transactivating activity by association with a novel splice variant of CCAAT-binding factor C subunit.
Chen F; Ogawa K; Liu X; Stringfield TM; Chen Y
Biochem J; 2002 Jun; 364(Pt 2):571-7. PubMed ID: 12023901
[TBL] [Abstract][Full Text] [Related]
18. Modeling and analysis of MH1 domain of Smads and their interaction with promoter DNA sequence motif.
Makkar P; Metpally RP; Sangadala S; Reddy BV
J Mol Graph Model; 2009 Apr; 27(7):803-12. PubMed ID: 19157940
[TBL] [Abstract][Full Text] [Related]
19. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
20. Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import.
Xu L; Alarcón C; Cöl S; Massagué J
J Biol Chem; 2003 Oct; 278(43):42569-77. PubMed ID: 12917407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
